Page last updated: 2024-08-24

lamivudine and Child Development Deviations

lamivudine has been researched along with Child Development Deviations in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	2 (100.00)	2.80

Authors

Authors	Studies
Awadu, JE; Coventry, A; Ezeamama, AE; Giordani, B; Sikorskii, A; Zalwango, S	1
Acosta, S; Balogun, K; Guzman Lenis, MS; Mount, HT; Sarkar, A; Serghides, L	1

Other Studies

2 other study(ies) available for lamivudine and Child Development Deviations

Article	Year
Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children. International journal of environmental research and public health, 2022, 03-21, Volume: 19, Issue:6 Topics: Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Autism Spectrum Disorder; Child; Developmental Disabilities; Female; HIV Infections; Humans; Lamivudine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Uganda; Zidovudine	2022
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PloS one, 2020, Volume: 15, Issue:11 Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir	2020

Article

Year

Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.

International journal of environmental research and public health, 2022, 03-21, Volume: 19, Issue:6

Topics: Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Autism Spectrum Disorder; Child; Developmental Disabilities; Female; HIV Infections; Humans; Lamivudine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Uganda; Zidovudine

2022

In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.

PloS one, 2020, Volume: 15, Issue:11

Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir

2020